Clinical trials for breast cancer
87 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
#NCT02806258
HER2 Negative
HR Negative
HR Positive
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Hospitalier Universitaire de Grenoble (La Tronche), Hôpital Henri-Mondor AP-HP (Créteil), Hôpital Avicenne - AP-HP (Bobigny), Institut de radiothérapie et de radiochirurgie Hartmann - Elsan (Levallois-Perret) (and 1 more...)
CHU Grenoble
Phase 2
Breast cancer
#NCT02264678
HER2 Negative
HER2 Low
HER2 Positive
Locally Advanced
Metastatic
BRCA 1/2
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Léon Bérard (Lyon)
AstraZeneca
Phase 2
Breast cancer
#NCT02264678
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Léon Bérard (Lyon)
AstraZeneca
Phase 2
Breast cancer
#NCT05563220
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Hormone therapy
Chemotherapy
Gustave Roussy (Villejuif)
Stemline Therapeutics, Inc.
Phase 2
Breast cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux) (and 2 more...)
PMV Pharmaceuticals, Inc
Phase 2
Breast cancer
#NCT04104776
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 2 more...)
Constellation Pharmaceutique
Phase 2
Breast cancer
#NCT06162351
HER2 Negative
HER2 Low
HR Negative
Locally Advanced
Metastatic
Chemotherapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud)
Institut Curie
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05751798
MSI/dMMR
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Systemic Treatment-Naive
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05384626
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
BRAF
MET
HER2
RET
NTRK-1/2/3
KRAS G12C
KRAS non G12C
BRCA 1/2
AKT
PIK3CA
PALB2
ESR
FGFR
PTEN
MSI/dMMR
ATM
CDK12
HOXB13
CHEK 1/2
NRAS
Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2
Breast cancer
#NCT06175390
HER2 Negative
HR Negative
Localized
Systemic Treatment-Naive
BRCA 1/2
Institut Curie - Paris (Paris), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud)
Institut Curie